Skip to content

Clinical trials

Phase 1/2 Colorectal Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 1/2 Country / region: South Korea Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20141
20161
20172
20183
20193
20204
202110
20222
20232
20246
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13
Active, not recruiting10
Completed7
Terminated6
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
GlaxoSmithKline2
Hoffmann-La Roche2
Arcus Biosciences, Inc.1
AstraZeneca1
BeyondBio Inc.1
Boehringer Ingelheim1
Bold Therapeutics, Inc.1
Bolt Biotherapeutics, Inc.1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms40
Carcinoma, Non-Small-Cell Lung13
Stomach Neoplasms8
Breast Neoplasms7
Endometrial Neoplasms7
Head and Neck Neoplasms6
Lung Neoplasms6
Neoplasm Metastasis6
Ovarian Neoplasms6
Squamous Cell Carcinoma of Head and Neck6

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.